ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

Project 1

Active
Institution
Washington University, MO
Principal investigator
Ali Hassan Ellebedy
Funding
$782K
Duration
2024–2029
Open portfolio

Moonbase score

Still being scored

Abstract

PROJECT ABSTRACT - PROJECT 1 The induction of immune memory is the basis of vaccination, which arguably is the single most impactful medical intervention in human history. Nonetheless, vaccines generally have been less effective against respiratory viral infections. Indeed, the protection offered by currently licensed vaccines against the rapidly evolving respiratory viral pathogens influenza and SARS-CoV-2 is limited in breadth and short-lived in duration. These shortcomings have necessitated annual (or more frequent) booster immunizations against these viruses. There is an urgent need to understand the unique immunological challenges faced by these vaccines to be able to enhance their protective capacity and durability. Specifically, key knowledge gaps remain with respect to the clonal and functional dynamics of the germinal center (GC) response over time, and how these dynamics impact the durability, breadth, and ultimately the protective capacity of vaccine induced immune responses. In this Project, we will utilize cohorts of vaccinated adults with unique matched samples from blood, draining lymph nodes, and bone marrow and employ stable isotope labeling of proliferating cells to study at the cellular, molecular, and genetic levels how GC response dynamics impact qualitative and quantitative antibody, B cell, and T cell responses after influenza virus or SARS-CoV-2 vaccination. These innovative studies will provide new information on human immune responses and inform design of new vaccines targeting mutable respiratory pathogens.

LOADING MOONBASE SCORE

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESU19ZAI1-AM-Ivaccinesinfluenzabreadthvaccinationdurabilityrespiratorysars-cov-respiratory viral

Questions for Washington University

Answered by the team behind this research.

Same researchers, same institution, same topic, scored first.